Investment Visual

JNJ

Johnson & Johnson

Revenue by segment

FY2025, ended Dec 28, 2025

Earlier:

Segments by fiscal year

Segments by fiscal year
Line, in USD	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	2016	2014	2013	2012	2012
Innovative Medicine	60.4B	57.0B	54.8B	52.6B	51.7B	—	—	—	—	—	—	—	—	—	—
Medtech	33.8B	31.9B	30.4B	27.4B	27.1B	23.0B	26.0B	27.0B	26.6B	25.1B	25.1B	27.5B	28.5B	—	—
	—	—	—	—	—	59.6B	56.1B	54.6B	49.9B	46.8B	44.9B	46.8B	42.8B	67.2B	65.0B
Pharmaceutical	—	—	—	—	—	45.2B	42.2B	40.7B	36.3B	33.5B	31.4B	32.3B	28.1B	25.4B	24.4B
Consumer Health	—	—	—	—	—	14.5B	13.9B	13.9B	13.6B	13.3B	13.5B	14.5B	14.7B	14.4B	14.9B
Med Devices	—	—	—	—	—	—	—	—	—	—	—	—	—	27.4B	25.8B
Total	94.2B	88.8B	85.2B	80.0B	78.7B	82.6B	82.1B	81.6B	76.5B	71.9B	70.1B	74.3B	71.3B	67.2B	65.0B